Nitroglycerin

Half-Life (t½)
SL: 2m · IV: 2m
Formula
C3H5N3O9
Molecular Weight
227.09 g/mol
PubChem CID
4510
Aliases
GTN, Nitrostat, Nitro-Dur

Pharmacological Mechanism

Prodrug → intracellular reduction (mitochondrial ALDH-2) releases nitric oxide → guanylyl cyclase activation → cGMP → smooth muscle relaxation. Predominantly venous dilation (decreases preload) at low doses; coronary + arteriolar dilation at higher doses. Tolerance develops within 24 h of continuous exposure — nitrate-free interval essential.

Half-Life & Elimination Curve (SL: 2m · IV: 2m)

100%50%25%12.5%0%0h0×t½2m1×t½5m2×t½7m3×t½10m4×t½12m5×t½0×t½ (0h): 100% remaining (~0.254 µg/L)1×t½ (2m): 50% remaining (~0.127 µg/L)2×t½ (5m): 25% remaining (~0.0636 µg/L)3×t½ (7m): 12.5% remaining (~0.0318 µg/L)4×t½ (10m): 6.3% remaining (~0.0159 µg/L)5×t½ (12m): 3.1% remaining (~0.00795 µg/L)
Elimination (SL)
  • 0×t½0h100% (0.254 µg/L)
  • 1×t½2m50% (0.127 µg/L)
  • 2×t½5m25% (0.0636 µg/L)
  • 3×t½7m12.5% (0.0318 µg/L)
  • 4×t½10m6.3% (0.0159 µg/L)
  • 5×t½12m3.1% (0.00795 µg/L)
Elimination t½2m (SL)
Rate Constant (ke)17.3 h⁻¹
Est. Peak (Cmax)0.254 µg/L
Clearance (CL)3640 L/h
97% Washout (5×t½)12m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References